Showing results (1-10 of 748) with videos related to
Sort By:
Pageof 75
Current Atherosclerosis Reports|January 31, 2024
How Will Our Practice Change After the CLEAR Outcomes Trial?Timothy Abrahams, Adam J Nelson, Stephen J NichollsThe Medical Clinics of North America|March 28, 2024
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and LipidsTimothy Abrahams, Stephen J Nicholls, Adam J NelsonCurrent Opinion in Cardiology|September 26, 2023
Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imagingTimothy Abrahams, Masashi Fujino, Adam J Nelson, et al.Expert Opinion on Drug Discovery|February 25, 2024
Perspectives on the success of plasma lipidomics in cardiovascular drug discovery and future challengesTimothy Abrahams, Stephen J NichollsCardiology Clinics|April 4, 2018
Treating Dyslipidemia in Type 2 DiabetesAdam J Nelson, Stephen J NichollsFuture Cardiology|March 18, 2020
Translating evidence from clinical trials of omega-3 fatty acids to clinical practiceAdam J Nelson, Stephen J NichollsExpert Opinion on Therapeutic Targets|May 30, 2024
New targets and mechanisms of action for lipid-lowering and anti-inflammatory therapies in atherosclerosis: where does the field stand?Stephen J Nicholls, Adam J NelsonCurrent Atherosclerosis Reports|November 21, 2022
CETP Inhibitors: Should We Continue to Pursue This Pathway?Stephen J Nicholls, Adam J NelsonAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 26, 2019
Rivaroxaban With or Without Aspirin for the Secondary Prevention of Cardiovascular Disease: Clinical Implications of the COMPASS TrialStephen J Nicholls, Adam J NelsonPageof 75